Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 254-413-8 | CAS number: 39318-18-8
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
No skin sensitization data of sufficient quality are available for tungsten blue oxide (target substance). However, skin sensitization data are available for tungsten trioxide (source substance), which will be used for read-across. Due to similar water solubility, in vitro bioaccessibility in synthetic sweat fluid simulating dermal exposure, and available toxicity data for the target and source substances, the resulting toxicity potential would also be expected to be similar, so read-across is appropriate between these substances. In addition, read-across is appropriate for this endpoint because the classification and labelling is the same for the source and target substances, the PBT/vPvB profile is the same, and the dose descriptors are, or are expected to be, sufficiently similar or more conservative for the target substance. For more details, refer to the attached description of the read-across approach.
Migrated from Short description of key information:
No skin sensitization data of sufficient quality are available for tungsten blue oxide. However, data are available for tungsten trioxide, which will be used for read-across. In a skin sensitization study conducted on guinea pigs and according to OECD 406, tungsten trioxide was deemed to be not sensitising.
Respiratory sensitisation
Endpoint conclusion
- Additional information:
Migrated from Short description of key information:
Although no study data specifically evaluating the potential respiratory sensitisation effects are available, based on the lack of human case reports indicating that tungsten blue oxide is a respiratory sensitiser, as well as negative responses observed in both the skin sensitisation and skin irritation animal studies, tungsten blue oxide is not likely to be a respiratory sensitiser
Justification for classification or non-classification
No skin sensitization data of sufficient quality are available for tungsten blue oxide. However, a skin sensitization test of sufficient quality and tested in accordance with standard methodology was available for tungsten trioxide. The results of this study showed that tungsten trioxide did not cause skin sensitization in Guinea Pigs. Therefore, based on read-across, no classification is required for the skin sensitization endpoint for tungsten blue oxide. No respiratory sensitization study is available for tungsten blue oxide. Therefore, classification cannot be made due to lack of data. However, this endpoint is not required for REACH registration.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Route: .live2